Maintenance strategy with fluoropyrimidines (FP) plus Bevacizumab (Bev), Bev alone, or no treatment, following a standard combination of FP, oxaliplatin (Ox), and Bev as first-line... von Arnold, Dirk, Graeven, Ullrich, Lerchenmuller, Christian A., Killing, Brigitta, Depenbusch, Reinhard, Steffens, Claus-Christoph, Al-Batran, Salah-Eddin, Lange, Thoralf, Dietrich, Georg, Stoehlmacher, Jan, Tannapfel, Andrea, Schmoll, Hans-Joachim, Reinacher-Schick, Anke, Hegewisch-Becker, Susanna

Volltext